About Xencor (XNCR)
Xencor, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing engineered monoclonal antibodies to treat severe and life threatening diseases. It has developed two clinical-stage product candidates, u... Read more
- USD19.27
- USD20.41
- USD19.14
- USD28.96
- -7.20%
- 168M
- 375.50k
- 538.77k
- 1.1B
- 16.49
- -25.70%
Stock News
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
